Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 34 for “"ROS1"”.
-
Deciphering and Targeting ALK- and ROS1-Driven Pediatric Gliomas
… receptor tyrosine kinases (RTKs), such as ALK, ROS1, NTRK1/2/3, and MET. Despite a relatively favorable prognosis, the optimal treatment strategies for IHGs remain undefined, and the biological consequences of RTK fusions are still poorly understood. This thesis investigates five IHG-associated …
-
ALK, MET und ROS1 Alterationen beim nicht-kleinzelligen Bronchialkarzinom
Hintergrund ALK, MET und ROS1 sind prädiktive und prognostische Marker, die beim nicht-kleinzelligen Bronchialkarzinom (NSCLC) mehr und mehr an Bedeutung gewinnen. Während ALK zunehmend Einzug in die Routinediagnostik erhält, werden weiterhin geeignete Methoden zum Nachweis von MET und ROS1 …
-
Dynamic regulation of DNA demethylation and RNA-directed DNA methylation in Arabidopsis
… In the model plant species Arabidopsis thaliana, ROS1 (REPRESSOR OF SILENCING 1) is one of the DNA demethylases and the key component in the demethylation pathway. Dysfunction of ROS1 leads to increase in DNA methylation level at thousands of genomic loci. However, the features of ROS1 targets are …
-
The role of CD74 in the development of resistance to tyrosine kinase inhibitors in ROS1- and ALK-fusion non-small cell lung cancer
… which DTP cells emerge is limited, especially in ROS1- and ALK-rearrangement NSCLCs. In a prior study, single-cell RNA-sequencing (scRNA-seq) analysis was performed and detected CD74 as a potential DTP candidate gene that may allow cells to enter a DTP state in NSCLC harboring an EGFR¬ mutation. …
-
Mecanismos envolvidos na regulação epigenética relacionada à tolerância a herbicidas em plantas
… dos 11 mutantes epigenéticos testados. O mutante ros1 teve aumento de 20 a 30% na suscetibilidade para glyphosate, imazethapyr e 2,4-D. ROS1 (REPRESSOR OF SILENCING 1) é uma 5-metil-citosina glicosilase, que atua como repressor de SGT. O efeito do imazethapyr sobre a metilação global do DNA (5mdC) …
-
An Unexpected Journey: A Medicinal Chemistry Exploration through the Realm of Protein Tyrosine Phosphatases, Signal Transducers, and Receptor Tyrosine Kinases
… and the proto-oncogene receptor tyrosine kinase (ROS1). Concerning PTP-1B, initial library screening and follow-up biological evaluation of a library of compounds led to a series of salicylic acid-based inhibitors. Additionally, absorption spectroscopy enzymatic assays intended for the evaluation …
-
Current state of precision therapy for the management of lung adenocarcinoma
… factor receptor (EGFR) and ROS proto-oncogene 1 (ROS1) directed therapies hold the most promise for improving clinical outcomes for EGFR mutant-positive and ROS1 fusion-positive patient populations. Though curative options will likely not be seen in the near future, the progress made by precision …
-
Understanding the interaction between RNA-directed DNA methylation and DNA demethylases and its role in Fusarium oxysporum disease response in Arabidopsis thaliana
… Demeter (DME), Repressor of silencing (ROS1) and Demeter-like 2 and 3 (DML2, DML3). Early studies in our laboratory have suggested DNA demethylases and RdDM work together to regulate plant defense-related genes and mediate Arabidopsis resistance against the fungal pathogen Fusarium …
-
Aplicaciones del factor de transcripción Rosea1 de la ruta de las antocianinas como marcador visual en virología molecular y biotecnología de plantas.
… del calabacín (ZYMV) etiquetado con Rosea1 (ZYMV-Ros1). El ZYMV es capaz de replicarse a nivel local pero no de moverse a larga distancia en plantas de Nicotiana benthamiana. Un análisis de la infección por ZYMV-Ros1 en una serie de plantas transgénicas de N. benthamiana silenciadas en distintas …
-
c-Met/HGF in triple negative breast cancer
… tyrosine kinases (FGFR1, FGFR3, VEGFR1, PDGFRβ, ROS1, TIE1 and EPHA5) which are associated with poor outcome (DFS/OS). Combined expression of FGFR3, EPHA5 and ROS1 shows significantly stronger association than the RTKs as single prognostic indicators. FGFR3 was associated with histological …
-
Μοριακή αποτύπωση των καρκινικών κυττάρων όγκων ασθενών με μη μικροκυτταρικό πρωτοπαθή καρκίνο πνεύμονα που υποβλήθηκαν σε χειρουργική επέμβαση και δεν εμφάνισαν μεταστάσεις
… General Hospital. EGFR, KRAS, BRAF, ALK, ROS1, and PD-L1 were evaluated in relation to clinical, imaging, and biochemical parameters including smoking exposure, preoperative PET/CT SUVmax, and corrected serum calcium. The final analysis included 170 patients with surgically resected NSCLC. …
-
Tomato chlorosis Virus: harnessing infectious Clones for reverse genetics and expression vector Development
… developed expression vectors for GFP and Ros1 proteins derived from the infectious clone of ToCV AT80/99, utilizing Nicotiana benthamiana plants via agroinoculation. Additionally, efforts were made to establish a controlled infection system for pepper plants by synthesizing the infectious …
-
Identification and characterization of factors involved in DNA demethylation and anti-silencing in Arabidopsis
… are known to function as regulatory factors for ROS1, a methylcytosine DNA glycosylase/lyase critical for active DNA demethylation. Our results suggest that MBD7 binds to genomic regions with dense and highly methylated CGs and prevents the spread of DNA methylation by recruiting other …
-
Digital Twin Platform for Drone Applications
… interfacing and integration with both ROS1 and ROS2, thereby ensuring seamless transfer of algorithms from simulation to hardware. To advance DRL research, a suite of deterministic and stochastic environments is introduced. These environments balance reproducibility and realism by …
-
Αναστολείς κινασών στην θεραπεία του μη μικροκυτταρικού καρκίνου του πνεύμονα
… μεταλλάξεις σε μόρια όπως EGFR, ALK, KRAS, ROS1, BRAF, MET, RET, VEGF, NTRK και HER2. Τα αποτελέσματα από διεθνείς μελέτες δείχνουν σημαντική βελτίωση στην επιβίωση χωρίς πρόοδο νόσου (PFS) και στην ολική επιβίωση (OS). Η ανάπτυξη αντοχής στους αναστολείς αυτούς παραμένει σημαντικό ζήτημα, …
-
Implementierung eines prädiktiven Biomarkers in den diagnostischen Routinealltag am Beispiel der Anaplastischen Lymphom Kinase (ALK) im nicht-kleinzelligen Lungenkarzinom (NSCLC)
… NGS-Panel neben ALK weitere Marker wie z.B. ROS1 parallel mit zu testen, um eine qualifizierte Entscheidung für eine optimale Therapie zu ermöglichen.
-
Teaching machine learning concepts through educational robotics
… Moveo and SelfLearn platforms were built in ROS1/Gazebo and used for design, simulation, and preparation. The pedagogical design aligned with Experiential Learning Theory (ELT), Computational Thinking (CT), and the AI4K12 guidelines. Evaluation employed mixed methods (pre/post knowledge and …
-
Mutacijų analizė nesmulkialąsteliniu plaučių vėžiu sergančių ligonių skysčių biopsijoje /
… BRAF, ERBB2, KRAS, MAP2K1, MET, NRAS, PIK3CA, ROS1 and TP53 somatic mutations. Changes in these genes by mutation, mutation frequency during disease progression could be used as molecular markers to detect LC formation, disease progression. The study was focused on analysing 11 gene attributed …
-
Resultados en el manejo del cáncer de pulmón avanzado en el Hospital Insular de Las Palmas de Gran Canaria entre los años 2009-2015
… un 4.8 de ALK positivo (n=20),y 1 paciente ROS1 y BRAF positivos. El 82% de los pacientes recibieron tratamiento de primera línea. El 77.1% quimioterapia (dobletes de platino el 97%), y el 5.1% TKI. La mediana de supervivencia global (mSG) fue de 15 meses. La mSG en histología no escamosa …
Page 1 of 2